Genflow Biosciences PLC

GENF

Company Profile

  • Business description

    Genflow Biosciences PLC is a preclinical biotechnology company focused on developing biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process, and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

  • Contact

    6 Heddon Street
    LondonW1B 4BT
    GBR

    T: +44 2081425409

    E: [email protected]

    https://www.genflowbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    5

Stocks News & Analysis

stocks

Chart of the Week: Opportunities with wide-moat retailers

Consumer defensive names look undervalued.
stocks

New ASX share added to our best ideas

Earnings outlook is strong and the shares trade at a discount to our fair value.
stocks

Fair value downgraded for ASX heavyweight

Our capital allocation rating was also lowered due to balance sheet weakness.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,240.3042.600.46%
CAC 408,054.4987.541.10%
DAX 4024,412.02298.401.24%
Dow JONES (US)46,441.1043.210.09%
FTSE 1009,443.852.58-0.03%
HKSE27,287.12431.561.61%
NASDAQ22,755.1695.150.42%
Nikkei 22544,936.73385.880.87%
NZX 50 Index13,451.7617.770.13%
S&P 5006,711.2022.740.34%
S&P/ASX 2008,945.9040.100.45%
SSE Composite Index3,882.7820.250.52%

Market Movers